Jennifer K. Moses
CIK 1706667 · CFO · last filed 2025-07-02
Jennifer K. Moses is a CFO who has filed 30 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for VRDN, was dated Jul 2, 2025. Across all open-market trades the lifetime net is −$378.4K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
30
-$378.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRDN | Director | — | $16.35 | — | $0 | 5 | 2025-07-02 |
| G1 Therapeutics, Inc. (GTHX) Delisted | CFO | 60,188 | $7.15 | $430.3K | -$378.4K | 25 | 2023-01-05 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-02 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2024-06-28 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +19,932 | -$13.1K | EDGAR |
| 2022-06-10 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2022-02-02 | G1 Therapeutics, Inc. (GTHX) Delisted | Exer (M) | +2,333 | $9.6K | EDGAR |
| 2022-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +10,555 | -$15.3K | EDGAR |
| 2021-07-15 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2021-03-04 | G1 Therapeutics, Inc. (GTHX) Delisted | Exer (M) | +3,000 | $11.2K | EDGAR |
| 2021-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +11,000 | $0 | EDGAR |